Tosaf Completes Acquisition of Adtec Colorant in the US

Israel’s Tosaf Group, a manufacturer of plastics additives, compounds and color masterbatches, has finalized the acquisition of US-based Adtec Colorant. Located in Arlington, Texas, Adtec manufactures specialty color concentrates, liquid and additive masterbatches for the injection-molding, blow-molding, film and extrusion markets. Financial terms were not disclosed.

Amos Megides, Tosaf’s chairman and CEO, commented: “This transaction represents another step in the fulfilment of our US market entry strategy following our earlier announcement of the construction of a new additives, white and color masterbatch plant in Bessemer City, North Carolina.”

He added that Adtec’s service offering would now be complemented by Tosaf’s many additional proprietary products as well as its extensive R&D capabilities.

Mahesh Parikh, founder and CEO of Adtec Colorant, said the acquisition would provide his company with rapid growth and enhance its products and technologies.

Tosaf is a joint venture between Megides Holding and Belgian plastics group Ravago with 10 manufacturing plants in Israel, Turkey, Germany, the Netherlands, the UK and China.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.